Serum vascular adhesion protein-1 is associated with twelve-year risk of incident cancer, cancer mortality, and all-cause mortality: a community-based cohort study
Journal
Frontiers in oncology
Journal Volume
13
Date Issued
2023
Author(s)
Chen, Szu-Chi
Yang, Chung-Yi
Hsu, Chih-Yao
Lyu, Ya-Pin
Juan, Hsien-Chia
Lin, Heng-Huei
Kuo, Chun-Heng
Abstract
Vascular adhesion protein-1 (VAP-1), a dual-function glycoprotein, has been reported to play a crucial role in inflammation and tumor progression. We conducted a community-based cohort study to investigate whether serum VAP-1 could be a potential biomarker for predicting incident cancers and mortality.
Subjects
all-cause mortality; cancer; cancer incidence; cancer mortality; vascular adhesion protein-1
SDGs
Type
journal article